NCT03749434View on ClinicalTrials.gov

Understanding and Addressing Variations in HAIs After Durable Ventricular Assist Device Therapy

CompletedOBSERVATIONAL
Enrollment

34,958

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Healthcare-Associated Infections
Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

University of Michigan

OTHER

NCT03749434 - Understanding and Addressing Variations in HAIs After Durable Ventricular Assist Device Therapy | Biotech Hunter | Biotech Hunter